Language

Women's Health Research

Women's Health Research Studies

Through the MultiCare Institute for Research & Innovation, women in our community have access to the latest treatment options through medical research. We rotate clinical trials for novelty medications and devices throughout the year for a wide variety of therapeutic areas including:

  • Contraception
  • Endometriosis
  • Female sexual dysfunction, libido
  • Hormone replacement therapy
  • Human papillomavirus (HPV)
  • Menopause
  • Overactive bladder
  • Uterine Fibroids
  • Vaginal infections

Principal Investigators:

Sub-Investigators:

Women's Health Studies Accepting Patients

HPV

HPV-301 Reveal I

Study Number: HPV-301—A prospective, randomized, double-blind, placebo-controlled Phase 3 study of VGX-3100 delivered intramuscularly followed by Electroporation Withcellectra 5PSP for the treatment of HPV-16 and/or HPV-18 related to high-grade squamous intraepithelial lesion (HSIL) of the cervix.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839

Endometriosis

Spirit 2

Study Number: MVT-601-3102—An international Phase III randomized, double-blind, placebo-controlled efficacy and safety study to evaluate Relugolix administered with and without low-dose Estradiol and Norethindrone Acetate in women with endometriosis-associated pain.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839

Female Sexual Dysfunction, Libido

VI-15-01

Study Number: VI-15-01—Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Stacy Rebar, [email protected], 253-403-7251

Uterine Fibroids

Liberty 2

Study Number: MVT-601-3002—An international Phase III randomized, double-blind, placebo-controlled efficacy and safety study to evaluate Relugolix co-administered with and without low-dose Estradoil and Norethindrone Acetate in women with heavy menstrual bleeding associated with uterine fibroids.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839


Asteroid 6

Study Number: Subgroup 2/BAY 1002670/16953 - An open-label, parallel group, randomized, multicenter study to assess the safety and efficacy of vilaprisan in subjects with uterine fibroids versus standard of care.

Study Info

Principal Investigator(s): James Rice, MD

Study CoordinatorLeann Harris, [email protected], 253-545-5839


ASTEROID 3

Study Number: BAYER 15787—A randomized, parallel-group, double-blind and open-label, placebo-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids.

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Leann Harris, [email protected], 253-545-5839

Overactive Bladder & Incontinence

Apollo

Study Number: 1839-201-021—A Phase III multicenter, randomized, double-blind, placebo-controlled, single-treatment, 2-stage, dose-finding study evaluating the efficacy and safety of BOTOX intravesical instillation in participants with overactive bladder and urinary incontinence.

Study Info

Principal Investigator(s): Krista Reagan, MD

Study CoordinatorDalia Sherif, [email protected], 253-403-2698

Bacterial Vaginosis

SMART GIVES

Study Number: SMART GIVES - Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety (SMART GIVES)

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Leann Harris, [email protected], 253-545-5839